ACM
MRTX

ADAR1 Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

ADAR1 Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-108,000
Closed -$6.35M – 282
2023
Q4 		$6.35M Buy
+108,000
New +$6.35M 2.27% 8